BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36387082)

  • 21. Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer.
    Connor CS; Kimler BF; Mammen JM; McGinness MK; Wagner JL; Alsop SM; Ward C; Fabian CJ; Khan QJ; Sharma P
    J Surg Oncol; 2015 Feb; 111(2):198-202. PubMed ID: 25266871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Kozak MM; von Eyben R; Gutkin PM; Vemuri M; Jacobson CE; Karl JJ; Walck E; Marquez C; Horst KC
    Clin Breast Cancer; 2021 Aug; 21(4):373-382. PubMed ID: 33766533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes.
    O'Halloran N; Lowery A; Curran C; McLaughlin R; Malone C; Sweeney K; Keane M; Kerin M
    Clin Breast Cancer; 2019 Oct; 19(5):377-382. PubMed ID: 31227416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Li X; Yan C; Xiao J; Xu X; Li Y; Wen X; Wei H
    Clin Breast Cancer; 2021 Oct; 21(5):e611-e617. PubMed ID: 34001440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
    van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
    Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
    Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
    Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
    JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
    Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the axilla following neoadjuvant chemotherapy for breast cancer- A change in practice.
    Riogi B; Sripadam R; Barker D; Harris O; Innes H; Chagla L
    Surgeon; 2021 Feb; 19(1):1-7. PubMed ID: 32192932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.
    Barron AU; Hoskin TL; Day CN; Hwang ES; Kuerer HM; Boughey JC
    JAMA Surg; 2018 Dec; 153(12):1120-1126. PubMed ID: 30193375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unplanned breast-conserving surgery after systemic therapy in locally advanced breast cancer: The results of level II oncoplastic techniques.
    Gulcelik MA; Dogan L
    Int J Clin Pract; 2021 Aug; 75(8):e14268. PubMed ID: 33891352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.
    Chen Y; Liu X; Yu K; Sun X; Xu S; Qiu P; Lv Z; Zhang X; Guo A; Xu Y
    Ann Transl Med; 2022 Jan; 10(2):93. PubMed ID: 35282081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
    Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
    Miyashita M; Niikura N; Kumamaru H; Miyata H; Iwamoto T; Kawai M; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Tsuda H; Nakamura S; Tokuda Y
    Ann Surg Oncol; 2019 Aug; 26(8):2475-2485. PubMed ID: 31102090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.